Intravenous injection of PCSK9 gain-of-function mutation in C57BL/6J background mice on Angiotensin II-induced AAA
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025
DOI: 10.1016/j.bbadis.2025.167657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Xingli Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese …. Hauptthemen laut MEDLINE: Angiotensin II, Aortic Aneurysm, Abdominal, Proprotein Convertase 9, Gain of Function Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study was performed to compare the incidence of Angiotensin II (Ang II)-induced abdominal aortic aneurysms (AAA) between intravenous and intraperitoneal injection of AAV8.mPCSK9 D377Y in wild-type (WT) mice with C57BL/6J background and the pathological differences of above model in WT and ApoE −/− mice.
Design
Male WT mice were injected intraperitoneally or intravenously with either a AAV8.null or AAV8.mPCSK9 D377Y . Two weeks after injection, all WT mice were infused with Ang II, and simultaneously age-matched male ApoE −/− mice were infused with saline or Ang II for 4 weeks.
Results
Compared with intraperitoneal injection of AAV8.mPCSK9 D377Y for AAA model in WT mice, a higher incidence of Ang II-induced AAA, increased blood pressure (BP) and lipid concentration, lower collagen deposition and up-regulated inflammation response were shown by intravenous injection , which was similar to ApoE −/− mice infused with Ang II.
Conclusion
AAV8.mPCSK9 D377Y infected male WT mice intravenously facilitate a high incident and comparable severity of Ang II-induced AAA which could be greatly expedites AAA studies on a gene of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese…
- Hepatology Department II, Qingdao Sixth People's Hospital, No. 9 Fushun Road, Qingdao, Shandong 266033, China.
- Department of Critical Care Medicine, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, Shandong 250012, China. Electronic address: wanghao34@126.com.
- Department of Critical Care Medicine, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, Shandong 250012, China. Electronic address: maoyangs@163.com.
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Xu, X., Li, X., Zhai, C., Yao, Y., Li, X., Ming, C., Sun, J., Wang, H., Mao, Y., & Zhang, L. (2025). Intravenous injection of PCSK9 gain-of-function mutation in C57BL/6J background mice on Angiotensin II-induced AAA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2025.167657
Vancouver
Xu X, Li X, Zhai C, Yao Y, Li X, Ming C, et al. Intravenous injection of PCSK9 gain-of-function mutation in C57BL/6J background mice on Angiotensin II-induced AAA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2025.167657
BibTeX
@article{Xu2025,
author = {Xu, Xingli and Li, Xiaohui and Zhai, Chungang and Yao, Yuxin and Li, Xiang and Ming, Chunjie and Sun, Juanjuan and Wang, Hao and Mao, Yang and Zhang, Lei},
title = {Intravenous injection of PCSK9 gain-of-function mutation in C57BL/6J background mice on Angiotensin II-induced AAA},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2025},
doi = {10.1016/j.bbadis.2025.167657}
}
EUVIMED